Showing results (861-870 of 894) with videos related to

Sort By:
Pageof 90
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
N,N-Dialkylated 4-(4-arylsulfonylpiperazine-1-carbonyl)-benzamidines and 4-((4-arylsulfonyl)-2-oxo-piperazin-1-ylmethyl)-benzamidines as potent factor Xa inhibitorsZhaozhong J Jia, Ting Su, Jingmei F Zuckett, et al.
Cell Reports|October 19, 2022
A molecular interactome of the glioblastoma perivascular niche reveals integrin binding sialoprotein as a mediator of tumor cell migrationYasmin Ghochani, Sree Deepthi Muthukrishnan, Alireza Sohrabi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 11, 2020
Cell-Based Therapy for Canavan Disease Using Human iPSC-Derived NPCs and OPCsLizhao Feng, Jianfei Chao, E Tian, et al.
Annals of Surgical Oncology|January 4, 2020
Correction to: Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric CancerElke J A H van Beek, Jonathan M Hernandez, Debra A Goldman, et al.
Neuro-Oncology|June 28, 2020
Clinical trial of proton craniospinal irradiation for leptomeningeal metastasesT Jonathan Yang, Neil A Wijetunga, Josh Yamada, et al.
Annals of Surgical Oncology|May 5, 2018
Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric CancerElke J A H van Beek, Jonathan M Hernandez, Debra A Goldman, et al.
Nature Neuroscience|March 20, 2026
Single-nucleus epigenomic profiling of the adult human central nervous system unveils epigenetic memory of developmental programsMukund Kabbe, Eneritz Agirre, Karl E Carlström, et al.
Nature Communications|October 19, 2022
P300 promotes tumor recurrence by regulating radiation-induced conversion of glioma stem cells to vascular-like cellsSree Deepthi Muthukrishnan, Riki Kawaguchi, Pooja Nair, et al.
The Review of Scientific Instruments|February 1, 2023
Developing a platform for Fresnel diffractive radiography with 1 μm spatial resolution at the National Ignition FacilityM O Schoelmerich, T Döppner, C H Allen, et al.
Pediatric Blood & Cancer|September 24, 2017
A phase II study of radioimmunotherapy with intraventricular 131 I-3F8 for medulloblastomaKim Kramer, Neeta Pandit-Taskar, John L Humm, et al.
Pageof 90